Cross Cultural Adaptation, Validity and Reliability Test of the Arabic Version of the Outpatient Physical Therapy Improvement in Movement Assessment Log (OPTIMAL)

February 27, 2024 updated by: Eman Hamdy Abdeltwab Hussien, Cairo University

Purpose of the study:

To translate, culturally adapt, and to test the validity and reliability of the Outpatient Physical Therapy Improvement in Movement Assessment Log in Arabic speaking language.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The OPTIMAL assessment log was produced in English and later on it was being validated into Italian and Spanish versions. It hasn't been produced into Arabic yet so the aim of this study is to test the validity , reliability and psychometric properties of this assessment tool when being translated into Arabic and used among the Arabic Egyptian people.

Study Type

Observational

Enrollment (Estimated)

880

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Egyptian adults who took at least a month of physiotherapy sessions.

Description

Inclusion Criteria:

  1. Participants are adult outpatients who took at least a month of physiotherapy sessions.
  2. Both genders will be included.
  3. At least 18 years of age.
  4. Participants must be conscious and ambulant.
  5. Participants able to read, write Arabic as a mother tongue and understand the instructions, questions in the questionnaire.

Exclusion Criteria:

Participants having the following conditions will be excluded from the study:

  1. Patients who are not able to provide informed consent.
  2. Patients who are unable to complete the OPTIMAL instrument.
  3. Patients who have a severe cognitive impairment.
  4. Patients who are not receiving physical therapy.
  5. Patients who are not Arabic-speaking.
  6. Patients who have a history of malingering

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
validity and reliability of the Egyptian Arabic language version of Outpatient Physical Therapy Improvement Movement Assessment Log on physical therapy outpatients.
Time Frame: Up to 24 weeks
to test if the Arabic version of this log is valid for usage among Egyptian People. Test improvement in different movements.
Up to 24 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2024

Primary Completion (Estimated)

March 1, 2024

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

January 14, 2024

First Submitted That Met QC Criteria

February 27, 2024

First Posted (Estimated)

February 28, 2024

Study Record Updates

Last Update Posted (Estimated)

February 28, 2024

Last Update Submitted That Met QC Criteria

February 27, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • OPTIMAL Arabic version

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Outpatients

Clinical Trials on Outpatient physical therapy improvement in movement assessment log

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe